Safety Reporting: postmarket
§ 314.80, Adverse Drug Experience (ADE)
§ 600.80, Biological product adverse experience
§ 606.170, Blood component adverse experience
§ 600.81, Vaccine adverse events (VAERS)
§ 803, Medical Device Reporting (MDR)